Global Prostacyclin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.

Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.

And in our report of prostacyclin, the “prostacyclin” means the drugs used for the treatment of pulmonary arterial hypertension.

Scope of the Report:
This report focuses on the Prostacyclin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.
The global average price of Prostacyclin is in the decreasing trend, from 60.2 USD/Unit in 2013 to 48.4 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
Prostacyclin is widely used for injection, for oral and for inhalation. The most proportion of Prostacyclin is used for oral, and the proportion in 2017 is about 55%. The trend of prostacyclin used for oral is increasing in the following years.
The worldwide market for Prostacyclin is expected to grow at a CAGR of roughly 5.5% over the next five years, will reach 2420 million US$ in 2023, from 1760 million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium

Market Segment by Applications, can be divided into
For Injection
For Oral
For Inhalation

There are 15 Chapters to deeply display the global Prostacyclin market.
Chapter 1, to describe Prostacyclin Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Prostacyclin, with sales, revenue, and price of Prostacyclin, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Prostacyclin, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Prostacyclin market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Prostacyclin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions